Drug Shortage Report for DIAZEPAM INJECTION USP

Last updated on 2019-05-04 History
Report ID 62442
Drug Identification Number 02385392
Brand name DIAZEPAM INJECTION USP
Common or Proper name DIAZEPAM INJECTION USP
Company Name HIKMA CANADA LIMITED
Market Status DORMANT
Active Ingredient(s) DIAZEPAM
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 2 mL
ATC code N05BA
ATC description ANXIOLYTICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2018-09-03
Estimated end date
Actual end date 2019-05-03
Shortage status Resolved
Updated date 2019-05-04
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v19 2019-05-04 English Compare
v18 2019-05-03 French Compare
v17 2019-05-03 English Compare
v16 2019-04-12 French Compare
v15 2019-04-12 English Compare
v14 2019-02-27 French Compare
v13 2019-02-27 English Compare
v12 2019-01-29 French Compare
v11 2019-01-29 English Compare
v10 2019-01-03 French Compare
v9 2019-01-03 English Compare
v8 2018-12-12 French Compare
v7 2018-12-12 English Compare
v6 2018-11-30 French Compare
v5 2018-11-30 English Compare
v4 2018-10-30 French Compare
v3 2018-10-30 English Compare
v2 2018-09-27 French Compare
v1 2018-09-27 English Compare

Showing 1 to 19 of 19